Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
The 2022–2023 ECDC PPS was the third EU-wide point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
This protocol describes a survey undertaken to acquire a snapshot of the distribution of Clostridioides difficile strains in tertiary acute care hospitals in the European Union/European Economic Area (EU/EEA) in 2022–2023
Resistance of Salmonella and Campylobacter bacteria to commonly used antimicrobials continues to be observed frequently in humans and animals, according to a report issued today by EFSA and ECDC.